The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / September / Bloodstream Infection Results in Hours
Biochemistry and molecular biology Infectious Disease Clinical care Molecular Pathology

Bloodstream Infection Results in Hours

Early results support further clinical validation of a direct-from-blood diagnostic workflow

09/25/2026 News 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary

Share

Clinical Scorecard: Bloodstream Infection Results in Hours

At a Glance

CategoryDetail
ConditionBloodstream Infection
Key MechanismsSingle-cell analysis platform for pathogen identification and antimicrobial susceptibility testing.
Target PopulationPatients with suspected bloodstream infections.
Care SettingLaboratory and clinical sample testing.

Key Highlights

  • Results produced in 6.75 to 17 hours for antimicrobial susceptibility testing.
  • 96% concordance with clinical laboratory identification in positive blood cultures.
  • 98% essential agreement and 94% categorical agreement for susceptibility testing.
  • Testing from human blood spiked with specific bacterial isolates.
  • Limitations include potential effects of prior antimicrobial exposure.

Guideline-Based Recommendations

Diagnosis

  • Utilize sedimentation-assisted tandem rocking and enrichment for analysis.

Management

  • Implement rapid identification and susceptibility testing for bloodstream pathogens.

Monitoring & Follow-up

  • Assess bacterial recovery and growth in the context of prior antimicrobial exposure.

Risks

  • Consider limitations in detecting fastidious or nonculturable organisms.

Patient & Prescribing Data

Patients with suspected bloodstream infections.

Rapid identification and susceptibility testing can inform timely treatment decisions.

Clinical Best Practices

  • Incorporate rapid testing workflows in clinical settings for improved patient outcomes.
  • Ensure validation of workflows in prospective studies with actual patient samples.

Related Resources & Content

  • Science Advances Study

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.